Lyell Immunopharma SG&A Expense (TTM) Trends

Lyell Immunopharma, Inc. (LYEL)

23.76 +0.83 (+3.62%) USD | NASDAQ | Jan 16, 16:00

23.86 +0.10 (+0.42%) After-Hours: 20:00

View SG&A Expense (TTM) for LYEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (TTM) Benchmarks

Start Trial

Insmed, Inc.	631.20M
Nektar Therapeutics	74.62M
GT Biopharma, Inc.	6.564M
Ionis Pharmaceuticals, Inc.	351.68M
Regeneron Pharmaceuticals, Inc.	2.717B